RDM1 and hepatocellular carcinoma: Loss of RAD52 motif 1 (RDM1), induced by methyltransferase‐like 3 (METTL3)‐mediated m6A modification, correlates with unfavorable clinical outcomes, promotes hepatocellular carcinoma (HCC) cell growth, and induces G2/M cell cycle arrest.